KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39

References

• Wang YC, Yang X, Wei WB, et al. Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein. Int J Ophthalmol. 2018;11(8):1258–1268.
   PubMed Web of Science ®Google Scholar
• Board PDQATE. Intraocular (uveal) melanoma treatment (PDQ(R)): health professional version. PDQ cancer information summaries. Bethesda (MD): National Cancer Institute (US); 2002.
   Google Scholar
• Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363(23):2191–2199.
   PubMed Web of Science ®Google Scholar
• Chua V, Aplin AE. Novel therapeutic strategies and targets in advanced uveal melanoma. Curr Opin Oncol. 2018;30(2):134–141.
   PubMed Web of Science ®Google Scholar
• Orenay-Boyacioglu S, Kasap E. Expression profiles of histone modification genes in gastric cancer progression. Mol Biol Rep. 2018;45:2275–2282.
   PubMed Web of Science ®Google Scholar
• Redon CE, Nakamura AJ, Martin OA, et al. Recent developments in the use of gamma-H2AX as a quantitative DNA double-strand break biomarker. Aging. 2011;3(2):168–174.
   PubMedGoogle Scholar
• Baltanas FC, Weruaga E, Valero J, et al. Albumin attenuates DNA damage in primary-cultured neurons. Neurosci Lett. 2009;450(1):23–26.
   PubMed Web of Science ®Google Scholar
• Liu Y, Long YH, Wang SQ, et al. Phosphorylation of H2A.X(T)(yr39) positively regulates DNA damage response and is linked to cancer progression. FEBS J. 2016;283(24):4462–4473.
   PubMed Web of Science ®Google Scholar
• Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008;8(12):957–967.
   PubMed Web of Science ®Google Scholar
• Georgoulis A, Vorgias CE, Chrousos GP, et al. Genome instability and gammaH2AX. Int J Mol Sci. 2017;18(9):1979.
   PubMed Web of Science ®Google Scholar
• Poulard C, Rambaud J, Lavergne E, et al. Role of JMJD6 in breast tumourigenesis. PLOS One. 2015;10(5):e0126181.
   PubMed Web of Science ®Google Scholar
• Liu Y, Long YH, Wang SQ, et al. JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity. Oncogene. 2018;38:980–997.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xing ZB, Zhang JH, et al. Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18. FEBS Lett. 2013;587(7):847–853.
   PubMed Web of Science ®Google Scholar
• Janssen RA, Veenstra KG, Jonasch P, et al. Ras- and Raf-induced down-modulation of non-muscle tropomyosin are MEK-independent. J Biol Chem. 1998;273(48):32182–32186.
   PubMed Web of Science ®Google Scholar
• Kidger AM, Sipthorp J, Cook SJ. ERK1/2 inhibitors: new weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway. Pharmacol Ther. 2018;187:45–60.
   PubMed Web of Science ®Google Scholar
• Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability–an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220–228.
   PubMed Web of Science ®Google Scholar
• Bao Y. Chromatin response to DNA double-strand break damage. Epigenomics. 2011;3(3):307–321.
   PubMed Web of Science ®Google Scholar
• Babchia N, Calipel A, Mouriaux F, et al. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Invest Ophthalmol Vis Sci. 2010;51(1):421–429.
   PubMed Web of Science ®Google Scholar
• Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599–602.
   PubMed Web of Science ®Google Scholar
• Corujo D, Buschbeck M. Post-translational modifications of H2A histone variants and their role in cancer. Cancers. 2018;10(3):59.
   PubMed Web of Science ®Google Scholar
• Nagelkerke A, van Kuijk SJ, Sweep FC, et al. Constitutive expression of gamma-H2AX has prognostic relevance in triple negative breast cancer. Radiother Oncol. 2011;101(1):39–45.
   PubMed Web of Science ®Google Scholar
• Warters RL, Adamson PJ, Pond CD, et al. Melanoma cells express elevated levels of phosphorylated histone H2AX foci. J Invest Dermatol. 2005;124(4):807–817.
   PubMed Web of Science ®Google Scholar
• Wasco MJ, Pu RT, Yu L, et al. Expression of gamma-H2AX in melanocytic lesions. Hum Pathol. 2008;39(11):1614–1620.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Wakai T, Kubota M, et al. DNA damage sensor gamma -H2AX is increased in preneoplastic lesions of hepatocellular carcinoma. ScientificWorldJournal. 2013;2013:1.
   Web of Science ®Google Scholar
• Nguyen LT, Song YW, Cho SK. Baicalein inhibits epithelial to mesenchymal transition via downregulation of Cyr61 and LOXL-2 in MDA-MB231 breast cancer cells. Mol Cells. 2016;39(12):909–914.
   PubMed Web of Science ®Google Scholar
• Mayer S, Gabriel B, Erbes T, et al. Cyr61 expression pattern and association with clinicopathological factors in patients with cervical cancer. Anticancer Res. 2017;37(5):2451–2456.
   PubMed Web of Science ®Google Scholar
• Wang P, Li L, Li T. Positive correlation of cysteine-rich 61 and target genes of Wnt/beta-catenin pathway in esophageal squamous cell carcinoma. J Can Res Ther. 2016;12:19–22.
   PubMed Web of Science ®Google Scholar
• Niu CC, Zhao C, Yang Z, et al. Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway. Cancer Cell Int. 2014;14(1):74.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu Y, Sun Q, et al. CYR61 suppresses growth of human malignant melanoma. Oncol Rep. 2016;36(5):2697–2704.
   PubMed Web of Science ®Google Scholar
• Ho GYF, Zheng SL, Cushman M, et al. Associations of insulin and IGFBP-3 with lung cancer susceptibility in current smokers. J Natl Cancer Inst. 2016;108(7):djw012.
   PubMedGoogle Scholar
• Johnson LM, Price DK, Figg WD. Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatment. Cancer Biol Ther. 2013;14(2):90–91.
   PubMed Web of Science ®Google Scholar
• Peng D, Hu Z, Wei X, et al. NT5E inhibition suppresses the growth of sunitinib-resistant cells and EMT course and AKT/GSK-3beta signaling pathway in renal cell cancer. IUBMB Life. 2018;71:113–124.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang X, Zhang M, et al. GPF15 promotes epithelial-to-mesenchymal transition in colorectal carcinoma. Artif Cells Nanomed Biotechnol. 2018;46:652–658.
   PubMed Web of Science ®Google Scholar
• Karasawa T, Kawashima A, Usui F, et al. Oligomerized CARD16 promotes caspase-1 assembly and IL-1beta processing. FEBS Open Biol. 2015;5(1):348–356.
   PubMed Web of Science ®Google Scholar
• Wienken M, Moll UM, Dobbelstein M. Mdm2 as a chromatin modifier. J Mol Cell Biol. 2017;9(1):74–80.
   PubMed Web of Science ®Google Scholar
• Minsky N, Oren M. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell. 2004;16(4):631–639.
   PubMed Web of Science ®Google Scholar
• Feeley KP, Adams CM, Mitra R, et al. Mdm2 is required for survival and growth of p53-deficient cancer cells. Cancer Res. 2017;77(14):3823–3833.
   PubMed Web of Science ®Google Scholar